ConductScience.org, home

Paper5487541

The chemotactic activity for neutrophil and eosinophil leucocytes of the trimolecular complex of the fifth, sixth and seventh components of human complement (C567) prepared in free solution by the 'reactive lysis' procedure.

Lachmann PJ and 2 others. Immunology, 1970. Cited by 97 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The chemotactic activity for neutrophil and eosinophil leucocytes of the trimolecular complex of the fifth, sixth and seventh components of human complement (C567) prepared in free solution by the 'reactive lysis' procedure. Papers, record 5487541. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5487541

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The chemotactic activity for neutrophil and eosinophil leucocytes of the trimolecular complex of the fifth, sixth and seventh components of human complement (C567) prepared in free solution by the 'reactive lysis' procedure.
PubMed
Journal
Immunology
PubMed
Year
1970
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
97
iCite
Relative citation ratio, by iCite
2.99
iCite
Revised in PubMed
2018-11-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lachmann PJP J
2Kay ABA B
3Thompson RAR A

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Binding SitesMajor topic
ChemotaxisMajor topic
Complement System ProteinsMajor topic
EosinophilsMajor topic
HemolysisMajor topic
NeutrophilsMajor topic
Antigen-Antibody Reactions
Blood Cell Count
Cell Membrane
Erythrocytes
Humans
Zymosan

Source PubMed

Download CSV of topics

References7

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14162237Further studies on the chemotactic factor of complement and its formation in vivo.Immunology1966https://conductscience.org/library/papers/4162237PubMed
25778389Macrophage and neutrophil specific chemotactic factors in serum.Nature1969https://conductscience.org/library/papers/5778389PubMed
35769979Studies on chemotaxis. XII. Generation of chemotactic activity for polymorphonuclear leucocytes in sera with complement dificiencies.Immunology1969https://conductscience.org/library/papers/5769979PubMed
45805427A neutrophil chemotatic factor derived from C'5 upon interaction of guinea pig serum with endotoxin.J Immunol1969https://conductscience.org/library/papers/5805427PubMed
55347695The eighth component of human complement (C8): isolation, characterization, and hemolytic efficiency.J Exp Med1969https://conductscience.org/library/papers/5347695PubMed
64992784Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes.Clin Exp Immunol1970https://conductscience.org/library/papers/4992784PubMed
713872176The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.J Exp Med1962https://conductscience.org/library/papers/13872176PubMed

Download CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 97 citations.

PMIDTitleJournalYearIn PapersSource
10444256In vitro and in vivo responses of murine granulocytes to human complement-derived, haemolytically inactive C5b67 (iC5b67).Clin Exp Immunol1999https://conductscience.org/library/papers/10444256PubMed
9151899The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity.J Exp Med1997https://conductscience.org/library/papers/9151899PubMed
7410543Eosinopenia of acute infection: Production of eosinopenia by chemotactic factors of acute inflammation.J Clin Invest1980https://conductscience.org/library/papers/7410543PubMed
7022723Mast cell-dependent effector pathways and cutaneous bullous disorders.Springer Semin Immunopathol1981https://conductscience.org/library/papers/7022723PubMed
6945600Platelet factor 4 is chemotactic for neutrophils and monocytes.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6945600PubMed
6336716
The mediation of tissue eosinophilia in hypersensitivity reactions. III. Separation of two different delayed eosinophil chemotactic factors and transfer of these factors by serum or cells from sensitized guinea-pigs.
Immunology1983https://conductscience.org/library/papers/6336716PubMed
6251111Constituents of human neutrophils that mediate enhanced adherence to surfaces: purification and identification as acidic proteins of the specific granules.J Clin Invest1980https://conductscience.org/library/papers/6251111PubMed
6227099Relationships among the complement, kinin, coagulation, and fibrinolytic systems.Springer Semin Immunopathol1983https://conductscience.org/library/papers/6227099PubMed
5045232Eosinophilia. II. Cutaneous eosinophilia in guinea-pigs mediated by passive anaphylaxis with IgGl or reagin, and antigen-antibody complexes; its relation to neutrophils and to mast cells.Immunology1972https://conductscience.org/library/papers/5045232PubMed
5009705A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.J Exp Med1972https://conductscience.org/library/papers/5009705PubMed
4729052The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator.J Clin Invest1973https://conductscience.org/library/papers/4729052PubMed
4641855A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization.J Exp Med1972https://conductscience.org/library/papers/4641855PubMed
4608469Modulation of the random migration of human platelets.J Clin Invest1974https://conductscience.org/library/papers/4608469PubMed
3759127C3-independent immune haemolysis: mechanism of membrane attack complex formation.Immunology1986https://conductscience.org/library/papers/3759127PubMed
1099121Hereditary deficiency of the seventh component of complement.J Clin Invest1975https://conductscience.org/library/papers/1099121PubMed
869976Primary restrictive cardiomyopathy. Non-tropical endomyocardial fibrosis and hypereosinophilic heart disease.Br Heart J1977https://conductscience.org/library/papers/869976PubMed
777027Hereditary deficiency of the fifth component of complement in man. II. Biological properties of C5-deficient human serum.J Clin Invest1976https://conductscience.org/library/papers/777027PubMed
383025The recruitment of inflammatory cells using the skin-window technique.Arch Dermatol Res1979https://conductscience.org/library/papers/383025PubMed
81295Eosinophilic granulocytes in cerebrospinal fluid: analysis of 94 cerebrospinal fluid specimens and review of the literature.J Neurol1978https://conductscience.org/library/papers/81295PubMed
64455Influence of serum-derived chemotactic factors and bacterial products on human neutrophil chemotaxis.Infect Immun1977https://conductscience.org/library/papers/64455PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5487541

GET https://conductscience.org/api/papers/v1/5487541/cited_by?page=2